Withdrawal from Opioids

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses how to identify and treat xylazine-associated wounds with patient-centered strategies.This didactic case-based session addresses national xylazine trends, drug properties, overdose and withdrawal management, wound care, pain management, and harm reduction with a focus on patient-centered care.

This correspondence provides updates on the May 2023 Xylazine Exposure Guidance and discusses implications for clinical practice and frontline public health.

This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.

This two-page pocket guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This quick start guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

The RODS is an 8-item screening tool to assess opioid depdence and the need for services for opioid use or withdrawal that require medical attention.

This toolkit, designed to augment overdose prevention and reversal training, provides guidance on the role of opioid overdose reversal medications, including naloxone and nalmefene, and how to respond to an overdose.

This guide focuses on using medication-assisted treatment for opioid use disorder in jails and prisons and during the reentry process when justice-involved persons return to the community. 

This Topic Brief provides an overview of what constitutes low-threshold treatment for patients with OUD, the state of the evidence and patient perspectives on low-threshold OUD treatment, and key steps and strategies for providing low-threshold treatment for patients with OUD in primary care settings.